Berger Montague PC examines Pfizer Inc.'s Board of Directors for violating trust (PFE) – Tradingview News

Philadelphia, Pennsylvania – (Newsfile Corp. – February 26, 2025) – Berger Montague advises the shareholders of Pfizer Inc. (“Pfizer” or “Company”) Pffe About an investigation by the Pfizer board of directors for potential violations of trust in Pfizer and its shareholders in connection with the marketing and sale of DEPO-Provera by the company.

Pfizer shareholders Can learn more about this examination by contacting Berger Montague: Radha Raghavan under rraghavan@bm.net or (332) 271-8908 or Andrew Abramowitz aabramowitz@bm.net or (215) 875-3015 or visit: https://investigations.bergermontague.com/pfizer/

The investigation by Berger Montaguue focuses on whether the Pfizer board of directors has violated its trust in the way in which it has been the marketing and sale of depo-provera by the company, an injectable company or the treatment of Endometriosis and other information. Sources have reported possible connections between long-term use of the Depo-Provera and an increased meningiome risk, a kind of brain tumor.

Berger Montague with branches in Philadelphia, Minneapolis, Delaware, Washington, DC, San Diego, Sane Francisco and Chicago has been a pioneer in shareholders since 1970. serves as a senior lawyer in courts in the United States.

Contacts:

Radha Raghavan, employee

Berger Montague

(332) 271-8908

rraghavan@bm.net

Andrew Abramowitz, Senior Counsel

Berger Montague

(215) 875-3015

aabramowitz@bm.net

To display the source version of this press release, please visit